Lupus clinical trials
Showing 51–100 of 106 active trials. Describe your situation to see which ones you may be eligible for.
- A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Dose Response of Exercise for Arthritis Management
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Open Label Treprostinil Raynaud's Study
- Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
- Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
- Study of Systemic Lupus Erythematosus
- Anifrolumab Pregnancy Study
- A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
- Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
- Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
- Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
- Cutaneous Lupus Registry
- Systemic Lupus Erythematosus in Gullah Health
- Duke Lupus Registry
- Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- US Zamto-cel Autoimmune Diseases
- Research Accelerated by You Lupus Registry
- Lupus Landmark Study: A Prospective Registry and Biorepository
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
- Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
- Direct to Patient Minimal Risk Biospecimen and Data Collection Research
- Deciphering the Genetic Architecture of Autoimmune Diseases
- Rheumatology Diet Study
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Rheumatology Patient Registry and Biorepository
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Intervention to Improve Communication and Medication Adherence in Lupus
- Creating Health Course Study for People With Rheumatological Conditions
- A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
- HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms
- Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus
- BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
- A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
- A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
- An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
- Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
- A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
- Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
- A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- Comparative Autoantibody and Immunologic Cell Marker Study
- A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.